Official Patient Website | ERLEADA® (apalutamide) ERLEADA ® is a prescription medicine used to treat two types of prostate cancer: Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or surgical treatment that lowers testosterone This is called metastatic castration-sensitive prostate cancer, or mCSPC OR Prostate cancer that HAS NOT SPREAD to other parts of the body and NO LONGER responds to a
Official Patient Website | ERLEADA® (apalutamide) ADT: Androgen deprivation therapy (ADT) includes medical or surgical treatment that lowers testosterone Chemotherapy: Type of drug(s) that kill cancer cells Median: The middle number in a set of numbers For 50% of people, this value was larger, and for 50% of people, it was smaller mCSPC: Metastatic castration-sensitive prostate cancer (mCSPC) is prostate cancer that HAS SPREAD to other
Official Patient Website | ERLEADA® (apalutamide) Take ERLEADA ® exactly as your healthcare provider tells you; Do not stop taking your prescribed dose of ERLEADA ® without talking with your healthcare provider first; Take your prescribed dose of ERLEADA ® 1 time a day, at the same time each day; Take ERLEADA ® with or without food; Swallow ERLEADA ® tablets whole Do not crush or split the tablets ; If you cannot swallow ERLEADA
Official Patient Website | ERLEADA® (apalutamide) What is metastatic castration-sensitive prostate cancer (mCSPC)? Prostate cancer that HAS SPREAD to other parts of the body and STILL RESPONDS to a medical or surgical treatment that lowers testosterone This is called metastatic castration-sensitive prostate cancer, or mCSPC The most common sites where prostate cancer can spread are bones, liver, and lungs
Official Patient Website | ERLEADA® (apalutamide) ERLEADA ® (apalutamide) is a prescription medicine used for the treatment of prostate cancer: that has spread to other parts of the body and still responds to a medical or surgical treatment that lowers testosterone, OR that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone